Dawn Bir | Chief Commercial Officer
Reata Pharmaceuticals

Dawn Bir, Chief Commercial Officer, Reata Pharmaceuticals

Dawn is Reata’s Chief Commercial Officer and leads marketing, market access, sales, training, and commercial operations. She joined Reata in September 2016. Prior to joining Reata, Dawn served as Vice President of Sales with Pharmacyclics, LLC, where she built and led their first hematology national sales organization of sales representatives, division managers, and regional sales directors, and was responsible for the launch of IMBRUVICA in the United States and Puerto Rico. Before that, Dawn served as Vice President of Sales & Marketing with McKesson US Pharmaceutical, SKY Pharmaceuticals, and RxPak. She held positions of increasing responsibility within McKesson Corporation, Genentech, Inc., and Bristol-Myers Squibb Company. Dawn holds a B.S. in Biology from Binghamton University.


World Orphan Drug Congress USA 2018 - Conference Day Two @ 14:05

ROUNDTABLE 5: Startup building - building and leading start-up biotechs into successful companies and building the necessary platforms to support commercial goals

back to speakers